Stevens Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$248K Buy
2,397
+14
+0.6% +$1.59K 0.04% 197
2025
Q4
$240K Buy
2,383
+191
+9% +$20.7K 0.08% 183
2025
Q3
$270K Sell
2,192
-4,472
-67% -$555K 0.04% 211
2025
Q2
$800K Buy
6,664
+1,026
+18% +$137K 0.22% 89
2025
Q1
$830K Sell
5,638
-957
-15% -$146K 0.21% 84
2024
Q4
$1.07M Buy
6,595
+1,602
+32% +$262K 0.43% 53
2024
Q3
$813K Buy
4,993
+1,189
+31% +$176K 0.12% 85
2024
Q2
$519K Sell
3,804
-9,655
-72% -$1.34M 0.18% 113
2024
Q1
$2.06M Buy
+13,459
New +$2.01M 0.4% 54
2023
Q4
Sell
-11,406
Closed -$1.5M 260
2023
Q3
$1.5M Buy
11,406
+7,480
+191% +$1.14M 0.43% 57
2023
Q2
$624K Buy
+3,926
New +$633K 0.13% 155
2022
Q3
Sell
-2,049
Closed -$289K 140
2022
Q2
$289K Buy
+2,049
New +$293K 0.2% 88
2020
Q4
Sell
-3,446
Closed -$724K 171
2020
Q3
$724K Sell
3,446
-588
-15% -$131K 0.27% 63
2020
Q2
$885K Buy
+4,034
New +$806K 0.33% 51
2019
Q4
Sell
-18,011
Closed -$2.73M 628
2019
Q3
$2.73M Sell
18,011
-9,594
-35% -$1.52M 0.25% 114
2019
Q2
$4.23M Sell
27,605
-51,627
-65% -$7.89M 0.19% 151
2019
Q1
$12.7M Buy
79,232
+20,223
+34% +$3.14M 0.54% 42
2018
Q4
$9.1M Sell
59,009
-45,344
-43% -$7.06M 0.47% 43
2018
Q3
$15.7M Buy
104,353
+2,667
+3% +$379K 0.57% 36
2018
Q2
$13.8M Buy
101,686
+27,001
+36% +$3.33M 0.49% 54
2018
Q1
$9.94M Buy
+74,685
New +$10M 0.38% 78
2017
Q3
Sell
-73,306
Closed -$9.77M 872
2017
Q2
$9.77M Buy
73,306
+22,456
+44% +$3.03M 0.37% 68
2017
Q1
$6.86M Buy
+50,850
New +$6.59M 0.26% 117
2016
Q4
Sell
-31,744
Closed -$3.97M 903
2016
Q3
$3.97M Buy
+31,744
New +$4.16M 0.17% 164
2016
Q2
Sell
-63,514
Closed -$8.01M 925
2016
Q1
$8.01M Buy
63,514
+46,248
+268% +$5.88M 0.32% 98
2015
Q4
$2.19M Buy
+17,266
New +$2.14M 0.09% 271
2015
Q3
Sell
-90,005
Closed -$9.36M 1006
2015
Q2
$9.36M Buy
+90,005
New +$9.71M 0.34% 83
2014
Q2
Sell
-35,987
Closed -$3.17M 1084
2014
Q1
$3.17M Buy
+35,987
New +$3.16M 0.09% 259

Other funds holding CLX

Stevens Capital Management's CLX Position: Q1 2026 in Review

Stevens Capital Management increased its Clorox (CLX) stake by 0.59% in Q1 2026, buying an estimated $1.59K and bringing the position to 2,397 shares worth $248K. The position accounts for 0.04% of the portfolio, ranked #197.

Stevens Capital Management first reported a position in CLX in Q1 2014 and has held it in 28 quarters since. The position peaked at $15.7M in Q3 2018. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Stevens Capital Management held 2,397 shares of Clorox worth $248K as of Q1 2026.
  • Stevens Capital Management bought 14 Clorox shares in Q1 2026, an estimated $1.59K.
  • Clorox made up 0.04% of Stevens Capital Management's portfolio in Q1 2026, its #197 holding.
  • Stevens Capital Management first reported a position in Clorox in Q1 2014 and has held it in 28 quarters since.
  • Stevens Capital Management's Clorox position peaked at $15.7M in Q3 2018.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Stevens Capital Management's 13F filing for Q1 2026, filed 11 May 2026.